0001127602-24-018569.txt : 20240613
0001127602-24-018569.hdr.sgml : 20240613
20240613164648
ACCESSION NUMBER: 0001127602-24-018569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240611
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mellion Michelle L
CENTRAL INDEX KEY: 0001923040
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41374
FILM NUMBER: 241041895
MAIL ADDRESS:
STREET 1: PEPGEN INC.
STREET 2: 245 MAIN ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PepGen Inc.
CENTRAL INDEX KEY: 0001835597
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 MARINA PARK DRIVE, SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 703-456-8000
MAIL ADDRESS:
STREET 1: 1 MARINA PARK DRIVE, SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-06-11
0001835597
PepGen Inc.
PEPG
0001923040
Mellion Michelle L
321 HARRISON AVE., 8TH FLOOR
C/O PEPGEN INC.
BOSTON
MA
02118
1
Chief Medical Officer
1
Common Stock
2024-06-11
4
M
0
500
10.21
A
500
D
Common Stock
2024-06-11
4
S
0
500
18.044
D
0
D
Common Stock
2024-06-12
4
M
0
1086
10.21
A
1086
D
Common Stock
2024-06-12
4
S
0
1086
18.0614
D
0
D
Stock Option (Right to Buy)
10.21
2024-06-11
4
M
0
500
0
D
2032-06-30
Common Stock
500
90844
D
Stock Option (Right to Buy)
10.21
2024-06-12
4
M
0
1086
0
D
2032-06-30
Common Stock
1086
89758
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This stock option vests over four years following the vesting commencement date (April 4, 2022) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date.
/s/ Noel Donnelly, as Attorney-in-Fact
2024-06-13